Analysis of antibiotic susceptibilities of skin wound flora in hospitalized dermatology patients: The crisis of antibiotic resistance has come to the surface

Archives of Dermatology

Volumn 134, Issue 8, 1998, Pages 1006-1009

  Colsky, Arthur S ^a   Kirsner, Robert S ^a   Kerdel, Francisco A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; CEFTAZIDIME; CIPROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; OXACILLIN; PENICILLIN G; TETRACYCLINE; TICARCILLIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; HOSPITALIZATION; HUMAN; LEG ULCER; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SKIN FLORA; SKIN INJURY; STAPHYLOCOCCUS AUREUS; WOUND CARE;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DERMATITIS; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS FAECALIS; ERYTHROMYCIN; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITALIZATION; HUMANS; LEG ULCER; OFLOXACIN; OXACILLIN; PEMPHIGOID, BULLOUS; PENICILLIN RESISTANCE; POPULATION SURVEILLANCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PSORIASIS; RETROSPECTIVE STUDIES; SKIN DISEASES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0031949017     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Rammelkamp CH, Maxon T. Resistance of Staphylococcus aureus to the action of penicillin. Proc Soc Exp Biol Med. 1942;51:386.
2. Teng P, Falanga V, Kerdel FA. The microbiological evaluation of leg ulcers and infected dermatoses in patients requiring hospitalization. Wounds. 1993;5: 133-136.
3. Kunin CM. Resistance to antimicrobial drugs: a worldwide calamity. Ann Intern Med. 1993;118:557-561.
4. Jones RN. Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients. Am J Med. 1996;100(suppl):3S-12S.
5. Brown KS. Pharmaceutical and biotech firms taking on drug-resistant microbes. Scientist 1996;10:1.
6. Thornsberry C. Susceptibility of clinical bacterial isolates to ciprofloxacin in the United States. Infection. 1994;22(suppl 2):S80-S89.
7. Kresken M, Hafner D, Mittermayer H, et al. Prevalence of fluoroquinolone resistance in Europe. Infection. 1994;22(suppl 2):S90-S98.
8. Gold HS, Moellering RC. Antimicrobial-drug resistance. N Engl J Med. 1996; 335:1445-1453.
9. New project launched to track antibiotic resistance. Am J Hosp Pharm. 1994; 51:2874.
10. Murray BE. Can antibiotic resistance be controlled? N Engl J Med. 1994;330: 1229-1230.
11. Brook I, Frazier EH, Yeager JK. Microbiology of infected atopic dermatitis. Int J Dermatol. 1996;35:791-793.
12. Schwartz R, Das-Young LR, Ramirez-Ronda C, Frank E. Current and future management of serious skin and skin-structure infections. Am J Med. 1996;100 (suppl):90S-95S.
13. Gonzalez A, Schachner LA, Cleary T, et al. Pyoderma in childhood. Adv Dermatol. 1989;4:127.
14. Stratton CW, Ratner H, Johnston PE, Schaffner W. Focused microbiologic surveillance by a specific hospital unit as a sensitive means of defining antimicrobial resistance problems. Diagn Microbiol Infect Dis. 1992;15(suppl):11S-18S.
15. Thornsberry C, Yee C. Comparative activity of eight antimicrobial agents against clinical bacterial isolates from the United States, measured by two methods. Am J Med. 1996;100(suppl):26S-38S.
16. Jones RN, Kehrberg EN, Erwin ME, Anderson SC, and The Fluoroquinolone Resistance Group. Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States, I: study on the threat of emerging resistance: real or perceived? Diagn Microbiol Infect Dis. 1994;19:203-215.
17. Neu HC, Duma RJ, Jones RN, et al. Antibiotic resistance: epidemiology and therapeutics. Diagn Microbiol Infect Dis. 1992;15:53S-60S.
18. Ballow CH, Schentag JJ. Trends in antibiotic utilization and bacterial resistance: report of the National Nosocomial Resistance Surveillance Group. Diagn Microbiol Infect Dis. 1992;1:37S-42S.